Health Care [ 4/12 ] | Biotechnology [ 21/75 ]
NYSE ARCA | Common Stock
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy.
The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases.
Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 25 | 4.26 Increased by +951.62% | - |
| May 14, 25 | -9.92 Decreased by -1.77 K% | -8.50 Decreased by -16.71% |
| Feb 13, 25 | -0.12 Increased by +78.57% | -0.42 Increased by +71.43% |
| Nov 12, 24 | -0.49 Decreased by -2.10% | -0.51 Increased by +3.90% |
| Sep 26, 24 | -0.50 Increased by +45.05% | -0.51 Increased by +1.96% |
| May 15, 24 | -0.53 Increased by +15.87% | -0.50 Decreased by -6.00% |
| Feb 14, 24 | -0.56 Decreased by -330.77% | -0.20 Decreased by -180.00% |
| Nov 14, 23 | -0.48 Increased by +44.19% | -0.41 Decreased by -17.07% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 8.85 M Increased by +N/A% | 4.68 M Increased by +159.79% | Increased by +52.87% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by -100.00% | -2.23 M Increased by +72.97% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -4.81 M Increased by +42.96% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -2.44 M Increased by +68.86% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -7.82 M Decreased by -50.28% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 350.00 K Decreased by -80.14% | -8.25 M Increased by +15.98% | Decreased by -2.36 K% Decreased by -322.97% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -8.44 M Increased by +2.70% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 2.03 M Increased by +98.18% | -7.84 M Decreased by -389.72% | Decreased by -385.62% Decreased by -246.19% |